Malachite Innovations, Inc. (VBIO) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Los Angeles, CA, 미국. 현재 CEO는 Michael R. Cavanaugh CPA,.
VBIO 을(를) 보유 IPO 날짜 2022-01-31, 3 명의 정규직 직원, 에 상장 Other OTC.
Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.
